KaioM BioScience Co., Ltd.
Basic information
- Head office
- 6th Floor, Sumitomo Real Estate Nishishinjuku Building, 12-1 Honmachi 3-chome, Shibuya-ku, Tokyo 151-0071, Japan
- Chief executive
- Masamichi Koike
- Capital
- 1,554,710,000 (15 100 million)
- Employees (non-consolidated)
- 63 people
- Employees (consolidated)
- Start date
- 2005-02-08
- End date
Websites
Business
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
| Biotecnol Limited | ||||||||
|
|
||||||||
| ADC Therapeutics社 | ||||||||
|
|
||||||||
| 国立研究開発法人理化学研究所 | ||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
| Saitama Small and Medium Enterprise Development Corporation | ||||||||
|
|
||||||||
|
|
||||||||
| 株式会社イーベック |
Network
History
KaioM BioScience Co., Ltd. is a biotech venture founded in 2005. Since its establishment, it has been developing antibody-related technologies and engaging in drug discovery activities up to the present.![]()
Established KaioM BioScience Co., Ltd. (capital 10,000 thousand yen) in Bunkyo-ku, Tokyo, to commercialize the ADLib® system developed through joint research between the Genetic Dynamics Research Unit led by researcher Kunishi Ota of the National Institute of Advanced Industrial Science and Technology (currently our technical advisor) and the Saitama Prefecture Small and Medium Enterprise Promotion Corporation (currently the Saitama Prefecture Industrial Promotion Corporation).![]()
Entered into a joint research agreement with RIKEN to commercialize the ADLib® System and commenced research activities![]()
Obtained exclusive implementation rights with sublicense to third parties for commercialization of the core technology (ADLib® System) from RIKEN and the Japan Science and Technology Agency![]()
Signed a paid transfer agreement for patents related to the core technology (ADLib® System) with the Japan Science and Technology Agency![]()
Entered into a licensing agreement with Swiss company ADC Therapeutics for the development of ADC LIV-1205.![]()
Signed a transfer agreement for the cancer therapeutic candidate antibody Tb535H (now CBA-1535) and the antibody modification technology Tribody™.![]()
Commenced Phase 1 clinical trials of our first clinical development product, the cancer therapeutic candidate antibody CBA-1205.![]()
Signed a licensing agreement with Shanghai Henlius Biotech (headquarters, Shanghai) for the development, manufacturing, and sales of cancer therapeutic antibodies LIV-2008 and LIV-2008b in the Greater China region (January 2023, license agreement terminated).![]()
Signed a licensing agreement with Shanghai Henlius Biotech (headquarters, Shanghai) for the development, manufacturing, and sales of cancer therapeutic antibodies LIV-2008 and LIV-2008b in the Greater China region.![]()
Transitioned from the Tokyo Stock Exchange Mothers market to the Growth market following a review of market classifications by the Tokyo Stock Exchange.![]()
News
There is no news.
Public records
National Tax Agency basic information6011101054960
- Trade name
- 株式会社カイオム・バイオサイエンス
- Trade name (kana)
- カイオムバイオサイエンス
- Name in English
- Corporation type
- 301
- Address
- 〒151-0071 東京都渋谷区本町3丁目12番1号
- Postal code
- 1510071
- Prefecture code
- 13
- City code
- 113
- Address outside Japan
- Prefecture in English
- City in English
- Address outside Japan in English
- Corporate number assignment date
- 2015-10-05
- Update date
- 2023-08-07
- Change date
- 2015-10-05
- Registry closure date
- Reason for registry closure
- Successor corporate number
- Details of the change
- Latest record
- 1
- Excluded from search
- 0
- Processing type
- 01
- Correction type
- 1
- Trade name image ID
- Address image ID
- Sequence number
- 2100376
METI gBizINFO6011101054960
- Corporate number
- 6011101054960
- Trade name
- 株式会社カイオム・バイオサイエンス
- Trade name (kana)
- カイオムバイオサイエンス
- Trade name (alphabet)
- Registry closure date
- Reason for registry closure
- Registered address
- 東京都渋谷区本町3丁目12番1号
- Postal code
- 1510071
- Prefecture
- 東京都
- Prefecture code
- 13
- City or district
- 渋谷区
- City code
- 113
- Street address
- 本町3丁目12番1号
- Organisation type
- 301
- Processing type
- 01
- Correction type
- 1
- Status
- Representative
- 代表取締役社長 小池 正道
- Capital
- 1085523000
- Employees
- 49
- Employees (male)
- Employees (female)
- Business summary
- Website URL
- Year founded
- Business category
- Date established
- Unified government qualification - grade
- Unified government qualification - business items
- Update date
- 2023-08-07
- Key information
- 6011101054960